Does INTERFERON BETA-1B Cause Therapy cessation? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Therapy cessation have been filed in association with INTERFERON BETA-1B (Betaseron). This represents 0.4% of all adverse event reports for INTERFERON BETA-1B.
46
Reports of Therapy cessation with INTERFERON BETA-1B
0.4%
of all INTERFERON BETA-1B reports
0
Deaths
6
Hospitalizations
How Dangerous Is Therapy cessation From INTERFERON BETA-1B?
Of the 46 reports, 6 (13.0%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA-1B. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does INTERFERON BETA-1B Cause?
Multiple sclerosis relapse (1,229)
Influenza like illness (1,042)
Injection site pain (1,014)
Fatigue (783)
Drug ineffective (767)
Injection site erythema (724)
Injection site reaction (707)
Pain (597)
Headache (596)
Multiple sclerosis (589)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which INTERFERON BETA-1B Alternatives Have Lower Therapy cessation Risk?
INTERFERON BETA-1B vs INTERFERON GAMMA
INTERFERON BETA-1B vs INTERFERON GAMMA-1B
INTERFERON BETA-1B vs INVEGA
INTERFERON BETA-1B vs INVEGA SUSTENNA
INTERFERON BETA-1B vs INVESTIGATIONAL BIOSIMILARS